Clinical trial NCT07159763 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-01-01 → 2027-06-01 3. primary completion date: 2027-01-01 → 2027-06-01 4. enrollment: 7500 → 10000 participants
Clinical trial NCT06351592 updates: 1. completion date: 2031-06-05 → 2032-03-21 2. primary completion date: 2031-06-05 → 2032-03-21 3. enrollment: 42 → 54 participants
Clinical trial NCT06785038: completion date: 2026-07-31 → 2027-01-31.
Clinical trial NCT05637099 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-04-29 3. enrollment: 266 → 181 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07011771 updates: 1. status: SUSPENDED → WITHDRAWN 2. completion date: 2029-11-01 → 2026-06-17 3. primary completion date: 2029-09-01 → 2026-06-17 4. enrollment: 31 → 0 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05325866: status: COMPLETED → TERMINATED.
Net Asset Value(s)
Clinical trial NCT06674577 updates: 1. completion date: 2028-05-31 → 2031-05-21 2. primary completion date: 2028-05-31 → 2031-05-21 3. enrollment: 476 → 750 participants
Clinical trial NCT07215390 updates: 1. start date: 2025-06-23 → 2025-09-29 2. completion date: 2027-11-01 → 2028-03-23 3. primary completion date: 2027-06-01 → 2027-09-25
Clinical trial NCT07552805 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-18 → 2026-06-16 3. completion date: 2027-11-19 → 2027-12-19 4. primary completion date: 2027-09-17 → 2027-10-17